FTX-301

N/A

Report date: 2025/01/26 17:16:35

Base Information

Drug NameFTX-301

Drug Alias NameAutologous Trilogy cell therapy (Falcon Therapeutics)genetically modified autologous induced skin cells combination therapy (Falcon Therapeutics)FTX-301

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasm Metastasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFalcon Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesFalcon Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasm Metastasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A